News & Press
-
Onkos Surgical Announces Definitive Agreement to Acquire the JTS Extendible Prosthesis
Company expands musculoskeletal oncology portfolio with device to treat pediatric bone cancer PARSIPPANY, N.J., June 13, 2022 /PRNewswire/ — Onkos Surgical, Inc., a rapidly growing, leading innovator of solutions for musculoskeletal oncology and complex orthopaedic conditions, announced today that it has entered into a definitive agreement with Stryker to acquire the Juvenile Tumour System (JTS). The…
Read More -
Onkos Surgical Raises $15 Million in Series C Funding
Funds will accelerate innovation, expand commercial presence, and drive manufacturing improvements in surgical solutions for musculoskeletal oncology and complex orthopaedics PARSIPPANY, N.J., Sept. 1, 2021— Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced that it has raised $15 million in Series C funding from its existing investor…
Read More -
Onkos Surgical Announces FDA 510(k) Clearance of its BioGrip® Modular Porous Collars, a First-of-Its-Kind Solution to Help Address Implant Loosening in Orthopaedic Oncology and Complex Revision Surgery
The new offering, available as part of the ELEOS™ Limb Salvage System, is designed to help support bone ingrowth in musculoskeletal oncology and complex orthopaedic limb salvage cases with a novel 3D-printed porous design PARSIPPANY, N.J., June 22, 2021— Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced…
Read More -
Onkos Surgical® Celebrates Patient Experience Week with Focus on Patient-Centered Innovation
PARSIPPANY, N.J., April 29, 2021 — In celebration of Patient Experience Week (April 26-30, 2021), Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced ongoing growth and adoption of its patient-centric innovations. These solutions are designed to help improve patient outcomes and experiences using the latest in precision…
Read More -
Onkos Surgical® continues its innovation in musculoskeletal oncology and complex orthopaedic reconstruction with the launch of the ELEOS™ Proximal Tibia with BioGrip™ technology
PARSIPPANY, New Jersey, December 21, 2020 – Onkos Surgical, Inc., an innovator in the field of musculoskeletal oncology and personalized orthopaedics, continues to deliver on its promise of commercializing innovative solutions with the launch of the new ELEOS Proximal Tibia with BioGrip technology. The product, used in complex tumor and orthopaedic reconstructive procedures, is the…
Read More -
Business Update Regarding COVID-19
March 27, 2020 – We recognize that our customers, patients, caregivers, and partners have a great deal of information coming from all directions during this rapidly changing time. This memorandum is a brief update regarding what Onkos Surgical is doing to ensure business continuity. First, on behalf of everyone at Onkos, we extend our gratitude…
Read More -
Onkos Surgical® to Launch New Personalized Surgery Platform with Disruptive Service Model for Joint Sparing Tumor Surgery
PARSIPPANY, New Jersey, September 26, 2019 – Onkos Surgical, Inc. announced today the launch of My3D™ Personalized Solutions powered by 3D Systems VSP® (Virtual Surgical Planning) Orthopaedics. The launch of this platform is the first of several products to be released under the companies’ previously announced collaboration to advance personalized solutions for tumor surgery. Patrick…
Read More -
Onkos Surgical® and Insight Medical Systems Team Up to Explore Applications of Augmented Reality in Musculoskeletal Oncology
PARSIPPANY, New Jersey, July 9, 2018 – Insight Medical Systems (Laguna Hills, CA) has teamed up with Onkos Surgical, Inc. (Parsippany, NJ) to explore opportunities to apply Insight Medical’s ARVIS™ (Augmented Reality Visualization and Information System) in musculoskeletal oncology. The companies are working on a pilot project to assess the technology for use in tumor surgery.
Read More -
ONKOS SURGICAL’s 3rd annual partnership with MSTS kicks off at the AAOS annual meeting in New Orleans
ONKOS SURGICAL’s 3rd Annual Partnership with MSTS Kicks Off at the AAOS Annual Meeting in New Orleans
Read More
-
Onkos Surgical® and 3D Systems Team to Advance Personalized Surgical Oncology Solutions
PARSIPPANY, New Jersey, March 6, 2018 – Onkos Surgical, Inc. announced today that it signed a 4-year agreement with 3D Systems (NYSE: DDD) to advance the delivery of personalized surgical solutions and help improve patient outcomes.
Read More -
Onkos Surgical® Announces Major Milestone with First Patient Entered in the Onkos Registry
Parsippany, NJ. (March 8, 2018) – Onkos Surgical, Inc., a specialty medtech company dedicated to advancing innovation for the surgical oncology market, announced today that Dr. Steven Gitelis and Rush University has entered the first patient in the Onkos Registry. The Onkos Registry is a multicenter, cloud based, HIPPA compliant platform designed to prospectively collect functional, psychosocial and oncological outcomes.
Read More -
ONKOS SURGICAL® Featured in MedTech Strategist
ONKOS Surgical is honored to be profiled in the January 2018 issue of The MedTech Strategist. Learn more about the company’s origins, our specialty medtech strategy and our focused approach to bringing innovation to musculoskeletal oncology surgeons and their patients.
Read More -
ONKOS SURGICAL® is ecstatic to be partnered with the Musculoskeletal Tumor Society in 2017
July was Sarcoma Awareness Month and we couldn’t think of a better time to honor the esteemed members of the Musculoskeletal Tumor Society (MSTS) and the work they do on a day to day basis. The members of the MSTS and the patients they treat
Read More -
Sarcoma Campaign Summary
Sarcoma Awareness Month Social Media Campaign July 2017 ONKOS SURGICAL Social Media Posts (All Outlets): July 1 What Does Sarcoma Awareness Mean to You? July 4 Happy 4th of July from ONKOS SURGICAL. July 6 Every Signature Makes a Big Difference! July 7 What Does Sarcoma Awareness Mean To You?
Read More -
Onkos Surgical ® Secures $17.6M in Series B Funding Led by Canaan Partners
Onkos Surgical, Inc., a specialty medtech company focused on surgical oncology, today announced that it closed a $17.6 million round in Series B funding. Canaan Partners led the funding round and existing investors 1315 Capital and 3D Systems also participated.
Read More -
Until 20 Screening
Thank you to everyone who supported the Onkos Surgical September 15th NJ screening of Until 20. It was a remarkable night as a packed theatre in Morristown was able witness the profound impact James Ragan had in the final years of his life. We were all reminded of the struggles…
Read More -
Onkos Surgical Supports Difficult Tumor Case with 3D Printed Medical Model
Onkos Surgical, a dedicated surgical oncology company founded to bring innovation, advocacy and passion to the surgical oncology marketplace, supported a difficult chondrosarcoma case with the use of a 3D printed medical model.
Read More -
Onkos Surgical Launches to Focus Exclusively on the Pediatric and Adult Surgical Oncology Market
Onkos Surgical, an innovative surgical oncology startup founded by Patrick Treacy, Antony Koblish and 1315 Capital, has announced it has closed a Series A round of financing led by 1315 Capital to bring innovation, advocacy and passion to the surgical oncology marketplace.
Read More